Kawasaki disease complicated by aspergillosis under cyclosporine and infliximab

Pediatr Int. 2022 Jan;64(1):e15300. doi: 10.1111/ped.15300.
No abstract available

Keywords: Kawasaki disease; aspergillosis; cyclosporine; infliximab; refractory.

Publication types

  • Case Reports

MeSH terms

  • Aspergillosis* / complications
  • Cyclosporine* / therapeutic use
  • Humans
  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents / therapeutic use
  • Infliximab* / therapeutic use
  • Mucocutaneous Lymph Node Syndrome* / complications
  • Mucocutaneous Lymph Node Syndrome* / diagnosis
  • Mucocutaneous Lymph Node Syndrome* / drug therapy

Substances

  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Cyclosporine
  • Infliximab